1. Home
  2. BHVN vs HIW Comparison

BHVN vs HIW Comparison

Compare BHVN & HIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • HIW
  • Stock Information
  • Founded
  • BHVN 2013
  • HIW 1978
  • Country
  • BHVN United States
  • HIW United States
  • Employees
  • BHVN N/A
  • HIW N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • HIW Real Estate Investment Trusts
  • Sector
  • BHVN Health Care
  • HIW Real Estate
  • Exchange
  • BHVN Nasdaq
  • HIW Nasdaq
  • Market Cap
  • BHVN 3.6B
  • HIW 3.4B
  • IPO Year
  • BHVN 2017
  • HIW 1994
  • Fundamental
  • Price
  • BHVN $36.17
  • HIW $30.09
  • Analyst Decision
  • BHVN Strong Buy
  • HIW Hold
  • Analyst Count
  • BHVN 13
  • HIW 5
  • Target Price
  • BHVN $63.00
  • HIW $31.20
  • AVG Volume (30 Days)
  • BHVN 1.1M
  • HIW 1.0M
  • Earning Date
  • BHVN 11-12-2024
  • HIW 02-04-2025
  • Dividend Yield
  • BHVN N/A
  • HIW 6.65%
  • EPS Growth
  • BHVN N/A
  • HIW 3.74
  • EPS
  • BHVN N/A
  • HIW 1.34
  • Revenue
  • BHVN N/A
  • HIW $829,290,000.00
  • Revenue This Year
  • BHVN N/A
  • HIW N/A
  • Revenue Next Year
  • BHVN $197.10
  • HIW $0.07
  • P/E Ratio
  • BHVN N/A
  • HIW $22.51
  • Revenue Growth
  • BHVN N/A
  • HIW N/A
  • 52 Week Low
  • BHVN $26.80
  • HIW $21.37
  • 52 Week High
  • BHVN $62.21
  • HIW $36.78
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 33.02
  • HIW 36.74
  • Support Level
  • BHVN $36.70
  • HIW $29.30
  • Resistance Level
  • BHVN $42.13
  • HIW $31.58
  • Average True Range (ATR)
  • BHVN 2.84
  • HIW 0.78
  • MACD
  • BHVN -0.67
  • HIW -0.11
  • Stochastic Oscillator
  • BHVN 13.18
  • HIW 28.11

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About HIW Highwoods Properties Inc.

Highwoods Properties Inc is a real estate investment trust engaged in the acquisition, ownership, management, and leasing of properties in urban areas throughout the Southern United States. In terms of total square footage, the vast majority of the company's real estate portfolio comprises office buildings in terms. Highwoods Properties derives nearly all of its income in the form of rental revenue from the tenants of its buildings. The majority of this revenue comes from its holdings in the urban markets of Atlanta, Raleigh, Nashville, and Tampa. These cities also account for the majority of the square footage under the company's ownership. Highwoods Properties' largest customers include the U.S. Government, financial services firms, industrial supply retailers, and healthcare companies.

Share on Social Networks: